Posted by Brigham and Women's Hospital August 9, 2016
Dr. Anthony D’Amico, Chief of the Genitourinary Oncology Program at Dana-Farber/Brigham and Women’s Cancer Center, is one of the featured speakers at the Annual Symposium on Prostate Cancer.
Would you like to learn about the latest in prostate cancer prevention, detection, and treatment? Join prostate cancer experts from Dana-Farber/Brigham and Women’s Cancer Center at the 18th Annual Symposium on Prostate Cancer on the evening of Wednesday, September 7, 2016 in Newton, Massachusetts. (See below to register.)
Featured speakers will include Dr. Anthony D’Amico, Chief of the Genitourinary Radiation Oncology Program at Dana-Farber/Brigham and Women’s Cancer Center; Dr. Mary-Ellen Taplin, Director of Clinical Research for the Lank Center for Genitourinary Oncology at Dana-Farber/Brigham and Women’s Cancer Center; Dr. Adam Kibel, Chief of Urologic Surgery at Brigham and Women’s Hospital and Dana-Farber/Brigham and Women’s Cancer Center, and Dr. Jerome Richie, Chief of Urologic Surgery (Emeritus) at Brigham and Women’s Hospital and Dana-Farber/Brigham and Women’s Cancer Center.
Our team of pioneering, nationally and internationally prominent specialists will discuss:
- Prevention with lifestyle modifications, including diet and exercise
- Controversies about early detection and screening using PSA and other novel biomarkers
- Surgical and radiation approaches, including newer less invasive techniques and procedures
- Prostate cancer staging
- Novel treatment for advanced prostate cancer
- Management of side effects of prostate cancer treatment
PLEASE NOTE THAT REGISTRATION IS REQUIRED TO ATTEND THIS EVENT. To register, please call us at 1-877-DFCI-BWH or register online.
Posted by Brigham and Women's Hospital January 1, 2013
The blog team at Brigham and Women’s Hospital would like to close out 2012 with a selection of our most popular posts. We’d also love to read about your favorites in our comments section.
We wish you a safe and happy New Year and look forward to sharing more health stories with you in 2013.
1. What’s in a Face?
After suffering a disfiguring injury, Dallas Wiens receives the gift of a new face – the first full face transplant in the U.S. – at Brigham and Women’s Hospital. The life-giving surgery, performed by a team of more than 30 physicians, nurses, anesthesiologists, and residents , provides Wiens with the typical facial features and function of any other man.
2. Prostate Cancer Screening – Should I or Shouldn’t I?
Dr. Anthony D’Amico, Professor and Chief of Genitourinary Radiation Oncology at Brigham and Women’s Hospital and Chief of the Prostate Cancer Radiation Oncology Service at Dana-Farber/Brigham and Women’s Cancer Center, discusses the benefits of prostate cancer screening, particularly for younger men.
Read More »
Posted by Brigham and Women's Hospital September 19, 2012
Patriots Hall of Famer Troy Brown gets a free PSA screening at the Brigham and Women's/Mass General Health Care Center.
Prostate cancer is the second most common and deadly cancer among
American men. About 1 in 6 men will be diagnosed with prostate cancer during their lifetime, and about 1 in 33 men will die from the disease.
The prostate-specific antigen (PSA) screening test is an important tool for helping to diagnose, monitor, and guide the treatment of this disease. Since the introduction of PSA screening more than 20 years ago, along with the advent of more aggressive treatment, there has been a dramatic increase in the survival rate of U.S. men diagnosed with prostate cancer. This includes, according to a recent study, a significant move toward resolving the disparity between prostate cancer survival rates in African-American men and Caucasian men.
Opinions on when a PSA screening should be performed, or whether it should be performed at all, vary widely among health care professionals. Brigham and Women’s Hospital continues to advocate the selective use of PSA. We believe that, overall, the benefits of PSA screening greatly outweigh the risks, particularly for young and/or healthy men at high risk and when prostate cancer specialists – oncologists and urologists – are interpreting the results to effectively limit unnecessary treatment.
Below is some important information for men who are considering PSA screening.
Read More »